top of page
Team Members
frontpage background.png

Innovative therapeutics with a de-risk approach 

PurMinds is a neuropharma company operating out of a neuro lab and production facility in Ontario, Canada. We develop novel therapeutics to address unmet medical needs by combining proven mechanism of action with cutting-edge discoveries in psychedelic research to accelerate drug development.

 

PurMinds owns and operates a portfolio of technical assets and special licenses that give the Company a competitive edge. We de-risk our enterprise portfolio by developing revenue-generating global API supply of both generic compounds and proprietary formulations.

1846975.jpg

Our People

Our team has the shared vision of solving complex medical problems that have a real and devastating impact on people close to us and around the world. It's what drives us. We are visionaries that strive to make our work really matter, and we measure our success by the advancement of our therapeutics that can help those in need.

Our Team

Janet_edited_edited.png

Founder,

President & Chief Executive Officer

A serial entrepreneur and strategic visionary with 15+ years of corporate banking experience and 8+ years of strategic management and business development work in investment, biotech and branding marketing field. 

Robin.png

Co-Founder &

Chief Commercial Officer

Expertise in developing asset growth strategies & paths to commercialization for biopharma, life science and botanical drug companies operating in the controlled drugs & substances space.

Max_edited_edited.png

Chief Scientific Officer

An accomplished biotech & pharma entrepreneur. Extensive experience in novel drug candidate/technology development, transfer, and commercialization in the biotechnology and life sciences space.

amy_edited.jpg

Chief Innovation Officer

A recognized leader in neuroscience and neuropharmacology; specializing in psychedelic clinical development, neurodegeneration, and  nutritional neurobiology; with 15 years of expertise in translational medicine spanning from molecules to mind 

Angelo_edited_edited.jpg

Chief Financial Officer

Senior Financial Leader with 30+ years experience in FP&A, Business Valuation, general accounting, risk management, and in driving financial and operational excellence.

Jian Chen Hi Res Pic_edited_edited.png

Vice President, NeuroLabs

Over 25 years of experience in laboratory operation and management, scientific research team leadership in chemistry, multi-omics for biomarker based precision medicine. 

Mike_edited.jpg

Clinical Investigator

Co-Principal Investigator of Psychedelic clinical trials and adjunct teaching faculty in Johns Hopkins University.

Bi Kim.png

Bi Kim, B.Sc.

Genetic Engineering 

Director, Technology & Innovation

Strong science background with extensive experience in research and development for laboratory and production technology. Ms. Kim plays a key role in the advancement of PurMinds botanical production process, and is desired to support the development of new therapies for devastating neurological diseases. 

Ed.jpg

Director, Quality and

Regulatory Affairs

With extensive experience and a long track-record in quality assurance and regulatory affairs, Mr. Wallace is helping Purminds navigate the regulatory framework of Health Canada, the US FDA and the European Medicines Agency (EMA).

Scientific Advisory Board

Tsai_edited_edited.png

Li-Huei Tsai

Ph.D.

Picower Professor of Neuroscience

Department of Brain and Cognitive Sciences

Director,

The Picower Institute for Learning and Memory
Co-Director,

Alana Down Syndrome Center

Senior Associate Member, Broad Institute
Massachusetts Institute of Technology

 

Finkbeiner_edited.png

Steven Finkbeiner

M.D., Ph.D.

Professor

Department of Neurology

Director,

Taube/Koret Center for Neurodegenerative Disease Research

Senior Investigator and Associate Director,

Gladstone Institute of Neurological Disease University of California, San Francisco

Shengtao Ho_edited_edited.png

Sheng-Tao Hou

Ph.D.

Professor of Neurobiology 

Director,

Brain Research Center

Southern University of Science and Technology (SUSTech)

Adjunct Professor

University of Ottawa Health Services 

Honorary Professor

Queensland Brain Institute

The University of Queensland (UQ)

Executive Director, 

SUSTech-UQ Joint Center for Neuroscience & Neural Engineering

Mathieu_edited.png

Mathieu Miron

Ph.D.

Partner & 

Patent Agent,

registered to act before the Canadian and United States Patent Offices, with specialties in biochemistry, organic chemistry, biotechnology, pharmaceutical inventions, food science, medical devices, simple mechanics and business methods

BENOÎT & CÔTÉ,

bottom of page